Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Prostatic Neoplasms 5Breast Neoplasms 4Ovarian Neoplasms 3Triple Negative Breast Neoplasms 2Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Overweight 2Obesity 2Multiple Myeloma 2Motor Activity 2Melanoma 2Lung Neoplasms 2Glioblastoma 2Colorectal Neoplasms 2Weight Loss 1Uveal Melanoma 1Smoking Cessation 1Quality of Life 1Postoperative Complications 1Patient Compliance 1Neoplasms 1Metabolic Syndrome 1Localized Prostate Carcinoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Insulin Resistance 1Inflammation 1Hypothalamic Neoplasms 1Healthy Diet 1Glioma 1Gastrointestinal Neoplasms 1

Interventions

Dexamethasone 238Lenalidomide 145daratumumab 123Bortezomib 101pomalidomide 86Calcium Dobesilate 76carfilzomib 74Cyclophosphamide 70Specimen Handling 42isatuximab 40Biopsy 40fludarabine 36belantamab mafodotin 36Magnetic Resonance Spectroscopy 35talquetamab 29dexamethasone acetate 27dexamethasone 21-phosphate 27Melphalan 27auricularum 26iberdomide 25ixazomib 22fludarabine phosphate 22selinexor 21elotuzumab 21Whole-Body Irradiation 14X-Rays 13tocilizumab 12venetoclax 11Mycophenolic Acid 10trametinib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Multiple Myeloma × Diet Therapy × 1 year × Clear all
NCT04497961 2025-09-11

A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
95 enrolled
Plasma cell

Multiple Myeloma

NCT06559709 2025-09-08

A Plant-Based Whole-Foods Meal Delivery Service for Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant

Fred Hutchinson Cancer Center

Phase NA Completed
26 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡